Prevention of breast cancer skeletal metastases with parathyroid hormone

Advanced breast cancer is frequently associated with skeletal metastases and accelerated bone loss. Recombinant parathyroid hormone [teriparatide, PTH(1-34)] is the first anabolic agent approved in the US for treatment of osteoporosis. While signaling through the PTH receptor in the osteoblast linea...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JCI Insight
Hlavní autoři: Swami, Srilatha, Johnson, Joshua, Bettinson, Lance A., Kimura, Takaharu, Zhu, Hui, Albertelli, Megan A., Johnson, Rachelle W., Wu, Joy Y.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5621896/
https://ncbi.nlm.nih.gov/pubmed/28878134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.90874
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky